Related references
Note: Only part of the references are listed.Development of new syndesmophytes and bridges in ankylosing spondylitis and their predictors: a longitudinal study
Astrid van Tubergen et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
MRI inflammation at the vertebral unit only marginally predicts new syndesmophyte formation: a multilevel analysis in patients with ankylosing spondylitis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Continuous NSAID use reverts the effects of in ammation on radiographic progression in patients with ankylosing spondylitis
Feline Kroon et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: results from the German Spondyloarthritis Inception Cohort
Denis Poddubnyy et al.
ANNALS OF THE RHEUMATIC DISEASES (2012)
ASAS recommendations for collecting, analysing and reporting NSAID intake in clinical trials/epidemiological studies in axial spondyloarthritis
Maxime Dougados et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis
Desiree van der Heijde et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Focal Fat Lesions at Vertebral Corners on Magnetic Resonance Imaging Predict the Development of New Syndesmophytes in Ankylosing Spondylitis
Praveena Chiowchanwisawakit et al.
ARTHRITIS AND RHEUMATISM (2011)
Resolution of Inflammation Following Treatment of Ankylosing Spondylitis Is Associated with New Bone Formation
Susanne J. Pedersen et al.
JOURNAL OF RHEUMATOLOGY (2011)
Persistent clinical efficacy and safety of infliximab in ankylosing spondylitis after 8 years-early clinical response predicts long-term outcome
Xenofon Baraliakos et al.
RHEUMATOLOGY (2011)
MRI and clinical findings in patients with ankylosing spondylitis eligible for anti-tumour necrosis factor therapy after a short course of etoricoxib
S. J. Jarrett et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
S. Visvanathan et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Development of a Radiographic Scoring Tool for Ankylosing Spondylitis Only Based on Bone Formation: Addition of the Thoracic Spine Improves Sensitivity to Change
X. Baraliakos et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2009)
Inflammatory Lesions of the Spine on Magnetic Resonance Imaging Predict the Development of New Syndesmophytes in Ankylosing Spondylitis
Walter P. Maksymowych et al.
ARTHRITIS AND RHEUMATISM (2009)
The Natural Course of Radiographic Progression in Ankylosing Spondylitis - Evidence for Major Individual Variations in a Large Proportion of Patients
Xenofon Baraliakos et al.
JOURNAL OF RHEUMATOLOGY (2009)
Assessment of radiographic progression in the spines of patients with ankylosing spondylitis treated with adalimumab for up to 2 years
Desiree van der Heijde et al.
ARTHRITIS RESEARCH & THERAPY (2009)
Critical appraisal of assessment of structural damage in ankylosing spondylitis
Joachim Sieper et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic Findings Following Two Years of Infliximab Therapy in Patients With Ankylosing Spondylitis
Desiree van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
Radiographic progression of ankylosing spondylitis after up to two years of treatment with etanercept
D. van der Heijde et al.
ARTHRITIS AND RHEUMATISM (2008)
The relationship between inflammation and new bone formation in patients with ankylosing spondylitis
Xenofon Baraliakos et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Radiographic progression in patients with ankylosing spondylitis after 4 yrs of treatment with the anti-TNF-α antibody infliximab
X. Baraliakos et al.
RHEUMATOLOGY (2007)
Progression of radiographic damage in patients with ankylosing spondylitis: defining the central role of syndesmophytes
X. Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
Major reduction in spinal inflammation in patients with ankylosing spondylitis after treatment with infliximab -: Results of a multicenter, randomized, double-blind, placebo-controlled magnetic resonance imaging study
J Braun et al.
ARTHRITIS AND RHEUMATISM (2006)
ASAS/EULAR recommendations for the management of ankylosing spondylitis
J Zochling et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Outcome of patients with active ankylosing spondylitis after two years of therapy with etanercept:: Clinical and magnetic resonance imaging data
X Baraliakos et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2005)
Radiographic progression in patients with ankylosing spondylitis after 2 years of treatment with the tumour necrosis factor a antibody infliximab
X Baraliakos et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis -: A randomized clinical trial
A Wanders et al.
ARTHRITIS AND RHEUMATISM (2005)
Assessment of outcome in ankylosing spondylitis: an extended radiographic scoring system
MCW Creemers et al.
ANNALS OF THE RHEUMATIC DISEASES (2005)
Clinical response to discontinuation of anti-TNF therapy in patients with ankylosing spondylitis after 3 years of continuous treatment with infliximab
X Baraliakos et al.
ARTHRITIS RESEARCH & THERAPY (2005)
What is the most appropriate radiologic scoring method for ankylosing spondylitis?
AJB Wanders et al.
ARTHRITIS AND RHEUMATISM (2004)
Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis
J Brandt et al.
ARTHRITIS AND RHEUMATISM (2003)
A nonparametric test for random dropouts
J Listing et al.
BIOMETRICAL JOURNAL (2003)
Treatment of active ankylosing spondylitis with infliximab:: a randomised controlled multicentre trial
J Braun et al.
LANCET (2002)
Share Paper
